182 related articles for article (PubMed ID: 2907957)
21. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
Okuyama S; Shimamura H; Hashimoto S; Aihara H
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
[TBL] [Abstract][Full Text] [Related]
23. Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
Collins P; Broekkamp CL; Jenner P; Marsden CD
Psychopharmacology (Berl); 1993; 112(4):428-36. PubMed ID: 7871053
[TBL] [Abstract][Full Text] [Related]
24. Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
Urbá-Holmgren R; Santos A; Holmgren B; Eguíbar JR
Behav Brain Res; 1993 Sep; 56(2):155-9. PubMed ID: 7902098
[TBL] [Abstract][Full Text] [Related]
25. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test.
Frussa-Filho R; Rocha JB; Conceição IM; Mello CF; Pereira ME
Arch Int Pharmacodyn Ther; 1996; 331(1):74-93. PubMed ID: 8896712
[TBL] [Abstract][Full Text] [Related]
26. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
Spina L; Longoni R; Mulas A; Di Chiara G
Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
Zarrindast MR; Jamshidzadeh A
Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.
Yamada K; Nagashima M; Kimura H; Matsumoto S; Furukawa T
Psychopharmacology (Berl); 1990; 100(2):141-4. PubMed ID: 1968276
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of dopamine agonists in mature and immature rats.
McDevitt JT; Setler PE
Eur J Pharmacol; 1981 Jun; 72(1):69-75. PubMed ID: 6973482
[TBL] [Abstract][Full Text] [Related]
31. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
Urba-Holmgren R; Holmgren B; Anias J
Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
[TBL] [Abstract][Full Text] [Related]
32. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of bifemelane hydrochloride and indeloxazine hydrochloride on scopolamine hydrobromide-induced impairment in radial maze performance.
Ogawa N; Haba K; Sora YH; Higashida A; Sato H; Ogawa S
Clin Ther; 1988; 10(6):704-11. PubMed ID: 3219685
[TBL] [Abstract][Full Text] [Related]
34. [The yawning behavior of rats following application of dopaminergic agonists--dose and time effect relationship].
Stelzig S; Hoffmann W
Pharmazie; 1988 Feb; 43(2):140-1. PubMed ID: 3393587
[No Abstract] [Full Text] [Related]
35. Effect of RG-tannin on yawning behaviour induced by apomorphine or physostigmine in rats.
Starec M; Waitzová D; Elis J
Act Nerv Super (Praha); 1989 Apr; 31(1):71-2. PubMed ID: 2571230
[No Abstract] [Full Text] [Related]
36. Involvement of central beta-adrenoceptors in the regulation of yawning responses.
Yamada K; Matsumoto S; Nagashima M; Kumagai M; Kimura H; Furukawa T
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):26-30. PubMed ID: 2571945
[TBL] [Abstract][Full Text] [Related]
37. Effect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393.
Skuza G; Rogóz Z; Zak J
Pol J Pharmacol Pharm; 1989; 41(5):421-9. PubMed ID: 2577061
[TBL] [Abstract][Full Text] [Related]
38. Atropine increases pilocarpine-induced yawning behavior in paradoxical sleep deprived rats.
Lobo LL; de Medeiros R; Hipólide DC; Tufik S
Pharmacol Biochem Behav; 1995 Nov; 52(3):485-8. PubMed ID: 8545463
[TBL] [Abstract][Full Text] [Related]
39. Effects of lead exposure on licking and yawning behaviour in rats.
Ghazi-Khansari M; Rezvani N; Bani-Assadi S; Zarrindast MR
Pharmacol Toxicol; 1998 Sep; 83(3):120-4. PubMed ID: 9783330
[TBL] [Abstract][Full Text] [Related]
40. Interaction of cholinergic and dopaminergic influences on yawning behavior.
Holmgren B; Urbá-Holmgren R
Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
